Who owns Verrica Pharmaceuticals Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VRCA from SEC Form 13F filings across 44 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 44 institutions disclosed 4.8M shares of Verrica Pharmaceuticals Inc. worth $28.7M — about 22.3% of shares outstanding; the largest disclosed holder is Caligan Partners LP. Source: SEC Form 13F filings, parsed by EvidInvest.
44
13F holders
$28.7M
value, 2026 filers
22.3%
of shares outstanding (4.8M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VRCA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Caligan Partners LP | 923,910 | $5.7M | 0.3% | 4.3% | 0.0% |
| 2 | CANNELL CAPITAL LLC | 783,923 | $4.8M | 3.2% | 3.7% | +14.4% |
| 3 | Affinity Asset Advisors, LLC | 707,338 | $4.3M | 0.2% | 3.3% | 0.0% |
| 4 | Velan Capital Investment Management LP | 471,559 | $2.9M | 1.8% | 2.2% | 0.0% |
| 5 | ARMISTICE CAPITAL, LLC | 426,304 | $2.6M | 0.0% | 2% | -17.7% |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 280,734 | $1.7M | 0.0% | 1.3% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 279,310 | $1.7M | 0.0% | 1.3% | +48.0% |
| 8 | Mariner, LLC | 207,230 | $1.3M | 0.0% | 1% | +744.3% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 138,160 | $845,656 | 0.0% | 0.6% | -0.5% |
| 10 | Stonepine Capital Management, LLC | 88,417 | $241,454 | 0.1% | 0.4% | -11.3% |
| 11 | BlackRock, Inc. | 74,344 | $454,986 | 0.0% | 0.3% | +92.8% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 70,173 | $429,459 | 0.0% | 0.3% | +7.8% |
| 13 | TWO SIGMA INVESTMENTS, LP | 40,825 | $249,849 | 0.0% | 0.2% | -19.4% |
| 14 | STATE STREET CORP | 28,916 | $176,966 | 0.0% | 0.1% | 0.0% |
| 15 | NORTHERN TRUST CORP | 26,996 | $165,216 | 0.0% | 0.1% | -14.5% |
| 16 | DAFNA Capital Management LLC | 23,750 | $145,350 | 0.0% | 0.1% | -84.5% |
| 17 | JANE STREET GROUP, LLC | 23,654 | $144,762 | 0.0% | 0.1% | -51.9% |
| 18 | Verdad Advisers, LP | 23,069 | $141,182 | 0.1% | 0.1% | +90.7% |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 21,769 | $133,226 | 0.0% | 0.1% | -32.7% |
| 20 | Legacy Trust | 16,584 | $101,494 | 0.0% | 0.1% | -3.8% |
| 21 | FIFTH THIRD BANCORPNEW | 14,000 | $85,680 | 0.0% | 0.1% | new |
| 22 | DIMENSIONAL FUND ADVISORS LPNEW | 13,888 | $84,995 | 0.0% | 0.1% | new |
| 23 | XTX Topco LtdNEW | 13,723 | $83,985 | 0.0% | 0.1% | new |
| 24 | TWO SIGMA SECURITIES, LLCNEW | 13,045 | $79,835 | 0.0% | 0.1% | new |
| 25 | HRT FINANCIAL LPNEW | 13,023 | $79 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.